title: TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-1 and upregulation of GATA-2 in an erythroid cell line SAM-1.
abstract: GATA-1 protein is thought to be a positive regulator of erythroid differentiation. However, ectopic expression of a conditional GATA-2/estrogen receptor chimera was shown to inhibit erythroid differentiation in a hormone-dependent manner, suggesting the negative regulation of erythroid differentiation by GATA-2 protein. Accordingly, we reasoned that the quantitative balance of GATA-1 and GATA-2 protein might affect erythroid differentiation. In this report, we performed specific and quantitative measurements of GATA-1 and GATA-2 protein in a new erythroid cell line, SAM-1, after treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA). On the basis of these measurements, we show that TPA-induced arrest of erythroid differentiation is coupled with the upregulation of GATA-2 protein, as well as the downregulation of GATA-1 protein. Our results suggest that it is the precise quantitative balance of GATA-1 and GATA-2 protein that regulates erythroid differentiation.
authors.affiliation: Laboratory of Experimental Radiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kamesaki
authors.forename: G Y
authors.initials: GY
authors.lastname: Michaud
authors.forename: S G
authors.initials: SG
authors.lastname: Irving
authors.forename: N
authors.initials: N
authors.lastname: Suwabe
authors.forename: S
authors.initials: S
authors.lastname: Kamesaki
authors.forename: M
authors.initials: M
authors.lastname: Okuma
authors.forename: J
authors.initials: J
authors.lastname: Cossman
mesh_terms: D000943:Antigens, Differentiation / Q000096:biosynthesis / Q000235:genetics; D015415:Biomarkers; D001752:Blast Crisis / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D015672:Erythroid Precursor Cells / Q000187:drug effects*; D050981:Erythroid-Specific DNA-Binding Factors; D004920:Erythropoiesis / Q000187:drug effects*; D050989:GATA2 Transcription Factor; D005786:Gene Expression Regulation / Q000187:drug effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology; D008533:Megakaryocytes / Q000166:cytology; D011960:Receptors, Estrogen / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D014407:Tumor Cells, Cultured
chemical_list: D000943:Antigens, Differentiation; D015415:Biomarkers; D004268:DNA-Binding Proteins; D050981:Erythroid-Specific DNA-Binding Factors; D050989:GATA2 Transcription Factor; D011960:Receptors, Estrogen; D011993:Recombinant Fusion Proteins; D014157:Transcription Factors; D013755:Tetradecanoylphorbol Acetate